Dr. Randy Yatscoff, a key member of the AllerGen network since 2010, has been awarded the Startup Canada Adam Chowaniec Lifetime Achievement Award. The award is presented to an individual who has demonstrated an “outstanding impact and enduring legacy” in …
Randy Yatscoff wins lifetime achievement award for Canadian entrepreneurship Read more »
Two AllerGen investigators were honoured at the Awards Dinner of the 2016 Canadian Society of Allergy and Clinical Immunology (CSACI) Annual Scientific Meeting held September 29 – October 2, 2016, in Montreal, QC. Dr. Bruce Mazer (McGill University) received the …
Food Allergy Canada—the community-based advocacy, information, education and research organization and valued AllerGen partner—has launched a new online training course for parents and caregivers entitled: “Anaphylaxis in the Community: What Parents and Others Need to Know.” Developed with Leap Learning Technologies …
AllerGen partner launches new anaphylaxis training course Read more »
AllerGen Scientific Director Dr. Judah Denburg and research leader Dr. Susan Elliott were among the presenters featured at the 6th Annual Meeting of (AQIA), held 30 September 2015 in Quebec City. The theme of the meeting was “Food Allergen Management: …
AllerGen speakers featured at AQIA Annual Meeting Read more »
How many Canadians visit emergency departments (ED) each year due to allergic reactions and anaphylaxis? Are the numbers growing? Which months are the most common for anaphylactic emergencies? How have prescription patterns for epinephrine auto-injectors changed over time? A new …
New report on Canadian anaphylaxis and allergic reactions in the emergency department Read more »
AllerGen research leader Dr. Paul O’Byrne has been appointed to the newly created Pulmonary Medical Advisory Board of Hydra Biosciences, a Massachusetts-based biopharmaceutical company that develops drugs to treat pain, inflammation, renal disease, anxiety and pulmonary disease. Dr. O’Byrne, a …
AllerGen researchers appointed to Hydra Biosciences Advisory Board Read more »
Dr. Kelly McNagny has been named a Co-Scientific Director of the Centre for Drug Research and Development (CDRD)—a national not-for-profit that speeds the development and commercialization of new drugs and health technologies emerging from Canada’s universities and research hospitals. Dr. …
AllerGen researcher Dr. Kelly McNagny named Co-Scientific Director of CDRD Read more »
A new consensus communication—issued jointly by Canadian, American and European allergists and the World Allergy Organization—recommends introducing peanut-containing products into the diet of “high risk” infants between four and 11 months of age. The Canadian Society of Allergy & Clinical …
Canadian allergists recommend early peanut introduction for “high risk” infants Read more »
AllerGen partner organization the Asthma Society of Canada is holding the event “Clearing the Air: Asthma and Allergies in a Time of Climate Change” on May 4 and 5, 2015, in Toronto, ON, to coincide with World Asthma Day. Motivated …
Dr. Kari Nadeau, one of North America’s foremost experts in adult and pediatric allergy, will lead the new Sean N. Parker Center for Allergy Research to be established at Stanford University in California. A US $24 million grant from technology …
Food allergy pioneer to head new research centre Read more »
Amazon chief Jeff Bezos and his wife have established a $2.24 million grant to support Dr. Kari Nadeau’s groundbreaking research at Stanford University to treat children with severe food allergies. The grant, which aims to raise matching funds through private …
Amazon’s Jeff Bezos supports food allergy research Read more »
Dr. Brett Finlay, a professor in the Departments of Biochemistry and Molecular Biology, and Microbiology and Immunology at The University of British Columbia (UBC), has been awarded the 2014 Prix Galien Canada Research Award. The Prix Galien recognizes outstanding contributions …
Rx&D bestows health research and innovation awards Read more »